Inovio Pharmaceuticals, Inc. (INO) income statement
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.76+0.05 (+2.92%)
Close on Nov 20, 2026Market cap $181.98MP/E –Yield –
Inovio Pharmaceuticals, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -183.5%
Financial strength
- Current ratio
- 1.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 79.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 41.63
- Dividend yield
- –
See a number that looks wrong?